StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.78−0.09 (-1.85%)

Close on Nov 18, 2026Market cap $789.85MP/E 6.2Yield –

Ironwood Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ironwood Pharmaceuticals's price to book ratio was 2.4× on Jul 31, 2023, against 3.4× a year earlier. Over the last 5 years it ranged from 2.3× to 312.4×, with a median of 9.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 20232.4×−0.8
2022Dec 30, 20223.2×−0.1
2021Dec 31, 20213.3×−305.5
2020Dec 31, 2020308.8×+300.2
2017Jan 31, 20178.7×−0.5
2016Dec 30, 20169.2×−3.0
2015Dec 31, 201512.2×−6.5
2014Dec 31, 201418.7×+7.4
2013Dec 31, 201311.3×+4.9
2012Dec 31, 20126.5×−2.7
2011Jul 29, 20119.2×–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?